USA
Acceder
Cotización de Deciphera Pharmaceuticals, Inc. (DCPH) hoy en tiempo real
Análisis técnico y gráfico histórico de Deciphera Pharmaceuticals, Inc.
Análisis fundamental y estadísticas clave de Deciphera Pharmaceuticals, Inc.
Ficha de Deciphera Pharmaceuticals, Inc. (DCPH)
| Ticker | DCPH |
|---|---|
| ISIN | US24344T1016 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Análisis financiero de Deciphera Pharmaceuticals, Inc.
Resumen financiero e información corporativa de Deciphera Pharmaceuticals, Inc.
Ratios de valoración: PER, EV/EBITDA y métricas de Deciphera Pharmaceuticals, Inc.
Márgenes de rentabilidad y Cash Flow de Deciphera Pharmaceuticals, Inc.
BPA, Dividendos y Valor Contable: Métricas por acción de Deciphera Pharmaceuticals, Inc.
Solvencia y deuda: Análisis del balance de Deciphera Pharmaceuticals, Inc.
Ratios de liquidez y Test Ácido: Capacidad de pago de Deciphera Pharmaceuticals, Inc.
Invertir en Deciphera Pharmaceuticals, Inc. en 2026: Preguntas frecuentes
¿Qué es Deciphera Pharmaceuticals, Inc.?
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an or...
¿En qué sector opera Deciphera Pharmaceuticals, Inc.?
Deciphera Pharmaceuticals, Inc. opera en el sector Healthcare, industria Drug Manufacturers - Specialty & Generic.
Otras acciones del sector Atención sanitaria